Trials / Completed
CompletedNCT04559984
JUVÉDERM VOLUX® for Chin Retrusion in China
A Randomized, Multicenter, "No-Treatment" Control Study to Evaluate the Safety and Effectiveness of JUVÉDERM VOLUX® Injectable Gel for the Enhancement of the Chin to Correct Moderate to Severe Retrusion in Chinese Adults
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 150 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the safety and effectiveness of JUVÉDERM VOLUX® to correct moderate to severe chin retrusion in Chinese adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | JUVÉDERM VOLUX® | JUVÉDERM VOLUX® injectable gel |
Timeline
- Start date
- 2020-10-15
- Primary completion
- 2022-08-26
- Completion
- 2022-08-26
- First posted
- 2020-09-23
- Last updated
- 2023-08-21
Locations
7 sites across 1 country: China
Source: ClinicalTrials.gov record NCT04559984. Inclusion in this directory is not an endorsement.